Brief: PCI Biotech: extension of preclinical research collaboration agreement

PCI Biotech Holding ASA

10/07/2017 07:00

July 10 (Reuters) - PCI BIOTECH HOLDING ASA  PCIB.OL : 
    * REG-PCI BIOTECH: EXTENSION OF PRECLINICAL RESEARCH 
COLLABORATION AGREEMENT WITH A TOP-10 LARGE PHARMA COMPANY 
    * ANNOUNCED THAT THEY ARE EXTENDING PRECLINICAL RESEARCH 
COLLABORATION WITH AN UNDISCLOSED TOP-10 PHARMA COMPANY, 
INITIATED IN SEPTEMBER 2015 
    * EXTENDED EVALUATION PERIOD SPANS OVER SIX MONTHS, UNTIL 
END OF 2017, AND MAY BE FURTHER EXTENDED 
    * PHARMA COMPANY IS ONE OF GLOBAL LEADERS IN NUCLEIC ACID 
THERAPEUTICS 
    * COMPANIES WILL EVALUATE DATA GENERATED IN THIS RESEARCH 
COLLABORATION AND EXPLORE POTENTIAL FOR A FURTHER PARTNERSHIP 
BASED ON THIS OUTCOME 
 
Source text for Eikon:  ID:nGNE7SJLXs  
Further company coverage:  PCIB.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))